Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06BDB
|
|||
| Former ID |
DNC008963
|
|||
| Drug Name |
Isosorbide-2-benzylcarbamate-5-acetate
|
|||
| Synonyms |
CHEMBL493460; Isosorbide-2-benzylcarbamate-5-acetate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H19NO6
|
|||
| Canonical SMILES |
CC(=O)OC1COC2C1OCC2OC(=O)NCC3=CC=CC=C3
|
|||
| InChI |
1S/C16H19NO6/c1-10(18)22-12-8-20-15-13(9-21-14(12)15)23-16(19)17-7-11-5-3-2-4-6-11/h2-6,12-15H,7-9H2,1H3,(H,17,19)/t12-,13+,14-,15-/m1/s1
|
|||
| InChIKey |
RMUIRACCZOGQBC-LXTVHRRPSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cholinesterase (BCHE) | Target Info | Inhibitor | [1] |
| Panther Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | |||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | ||||
| Nicotinic acetylcholine receptor signaling pathway | ||||
| WikiPathways | Irinotecan Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors. J Med Chem. 2008 Oct 23;51(20):6400-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.